Research ArticleOncology
Hospice Admission and Survival After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
Ilana F. Gareen, Bruce E. Hillner, Lucy Hanna, Rajesh Makineni, Fenghai Duan, Anthony F. Shields, Rathan M. Subramaniam and Barry A. Siegel
Journal of Nuclear Medicine March 2018, 59 (3) 427-433; DOI: https://doi.org/10.2967/jnumed.117.205120
Ilana F. Gareen
1Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island
2Center for Statistical Sciences, Brown University, Providence, Rhode Island
Bruce E. Hillner
3Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia
Lucy Hanna
2Center for Statistical Sciences, Brown University, Providence, Rhode Island
Rajesh Makineni
2Center for Statistical Sciences, Brown University, Providence, Rhode Island
Fenghai Duan
2Center for Statistical Sciences, Brown University, Providence, Rhode Island
4Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island
Anthony F. Shields
5Karmanos Cancer Institute, Wayne State University, Detroit, Michigan
Rathan M. Subramaniam
6Division of Nuclear Medicine, Department of Radiology, and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; and
Barry A. Siegel
7Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and the Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 59, Issue 3
March 1, 2018
Hospice Admission and Survival After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
Ilana F. Gareen, Bruce E. Hillner, Lucy Hanna, Rajesh Makineni, Fenghai Duan, Anthony F. Shields, Rathan M. Subramaniam, Barry A. Siegel
Journal of Nuclear Medicine Mar 2018, 59 (3) 427-433; DOI: 10.2967/jnumed.117.205120
Hospice Admission and Survival After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
Ilana F. Gareen, Bruce E. Hillner, Lucy Hanna, Rajesh Makineni, Fenghai Duan, Anthony F. Shields, Rathan M. Subramaniam, Barry A. Siegel
Journal of Nuclear Medicine Mar 2018, 59 (3) 427-433; DOI: 10.2967/jnumed.117.205120
Jump to section
Related Articles
Cited By...
- Prospective Study of Serial 18F-FDG PET and 18F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer
- The Injustice of Being Judged by the Errors of Others: The Tragic Tale of the Battle for PET Reimbursement
- The National Oncologic PET Registry (NOPR): A Monumental Effort by a Few Leaders